OMBCL Shorts #2: Dr. Erika Hamilton with Top Takeaways from ASCO23
Medical Community, Diagnosis and Treatment Our MBClife Medical Community, Diagnosis and Treatment Our MBClife

OMBCL Shorts #2: Dr. Erika Hamilton with Top Takeaways from ASCO23

Our second OMBCL Shorts features Dr. Erika Hamilton answering questions about her top takeaways from ASCO23. In this 20-minute interview we covered important updates on the CDK4/6 inhibitors for both early-stage and metastatic breast cancer, as well as research on a new HER3 ADC and the first AKT inhibitor for MBC.

Read More
2022 in Review: Best in MBC with Dr. Erika Hamilton
Quality of Life, Clinical Research, Novel Treatments, Challenges and Barriers, Medical Community, Clinical Trials Process, Obstacles to Better Outcomes Our MBClife Quality of Life, Clinical Research, Novel Treatments, Challenges and Barriers, Medical Community, Clinical Trials Process, Obstacles to Better Outcomes Our MBClife

2022 in Review: Best in MBC with Dr. Erika Hamilton

Welcome to the first Road to A Cure episode of Season 6. Our guest is the incomparable Dr. Erika Hamilton, a breast oncologist and researcher who, as she says herself, doesn’t shy away from difficult questions. In this episode, we get a review—subtype by subtype—of the biggest news over the past 15 months. Of course, we also talk about what is on the horizon in MBC.

Read More